Ovarian reserve modulates the impact of vitamin D deficiency on assisted reproductive outcomes in patients undergoing controlled ovarian hyperstimulation
- PMID: 39726869
- PMCID: PMC11670746
- DOI: 10.3389/fnut.2024.1486958
Ovarian reserve modulates the impact of vitamin D deficiency on assisted reproductive outcomes in patients undergoing controlled ovarian hyperstimulation
Abstract
Objective: The association between vitamin D deficiency and ovarian reserve-specific outcomes of assisted reproductive technology (ART) remains uncertain. This study aimed to investigate the role of ovarian reserve in the association between basal serum vitamin D levels and ART outcomes in patients undergoing controlled ovarian hyperstimulation (COH).
Methods: A total of 1,333 infertile women undergoing COH cycles were retrospectively analyzed. Patients were divided into a vitamin D deficiency group (serum vitamin D < 20 ng/mL) and a normal vitamin D group. Univariate and multivariate logistic regression analyses were performed to estimate the relationship between vitamin D deficiency and pregnancy outcomes including biochemical pregnancy rate, clinical pregnancy rate, miscarriage rate, and live birth rate in the overall cohort and subgroups with diminished ovarian reserve (DOR) or polycystic ovary syndrome (PCOS).
Results: In the entire participants' cohort, no correlation between vitamin D deficiency and pregnancy results was observed (p > 0.05). However, in the DOR subgroup, vitamin D deficiency was associated with a lower biochemical pregnancy rate (adjusted OR 0.27; 95% CI 0.08-0.90; p < 0.01) and clinical pregnancy rate (adjusted OR 0.36; 95% CI 0.14-0.90; p < 0.01). No significant differences were observed in pregnancy outcomes among patients with PCOS (p > 0.05).
Conclusion: Vitamin D deficiency does not affect pregnancy outcomes in the overall patient population, but it may negatively impact women with DOR potentially leading to poorer pregnancy outcomes. Further studies are needed to clarify the mechanisms involved and the potential use of vitamin D screening and supplementation in specific populations.
Keywords: assisted reproductive; controlled ovarian hyperstimulation; diminished ovarian reserve; in vitro fertilization; vitamin D.
Copyright © 2024 He, Xu, Hao, Ran, Qiu, Lin and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Identify high-risk DOR women ≤ 35 years old following assisted reproduction technology through cutoffs of anti-mullerian hormone and antral follicle counts.Reprod Biol Endocrinol. 2024 Oct 25;22(1):130. doi: 10.1186/s12958-024-01298-4. Reprod Biol Endocrinol. 2024. PMID: 39456075 Free PMC article.
-
The role of serum vitamin D in patients with normal ovarian reserve undergoing the first IVF/ICSI cycle.Front Endocrinol (Lausanne). 2023 Aug 24;14:1249445. doi: 10.3389/fendo.2023.1249445. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37693363 Free PMC article.
-
Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.Hum Reprod. 2015 Apr;30(4):840-7. doi: 10.1093/humrep/dev029. Epub 2015 Mar 3. Hum Reprod. 2015. PMID: 25740883
-
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4. Cochrane Database Syst Rev. 2020. PMID: 33347618 Free PMC article.
-
Association of ABO blood groups with ovarian reserve, and outcomes after assisted reproductive technology: systematic review and meta-analyses.Reprod Biol Endocrinol. 2021 Feb 6;19(1):20. doi: 10.1186/s12958-020-00685-x. Reprod Biol Endocrinol. 2021. PMID: 33549121 Free PMC article.
References
LinkOut - more resources
Full Text Sources